Budapest, May 30 (MTI) – Drugmaker GlaxoSmithKline (GSK) Biologicals inaugurated a new vaccine manufacturing unit in Gödöllő, on the outskirts of Budapest, on Monday.
Foreign Minister Péter Szijjártó said at the inauguration ceremony that in 2010 the Hungarian government set a new goal of making the country central Europe’s centre of production. He said the government had achieved considerable success in “reindustrialising” the economy, but Hungary must now become a centre for R+D and innovation.
He said the government tripled the amount of EU funds spent on R+D during the 2014-2020 funding period and the aim now is to increase R+D spending to 1.8 percent of GDP by 2020.
The pharmaceutical industry will have a key role to play in Hungary’s economic development, he said.